CEO Mccarthy Sean A. converted options into 37,500 shares and sold $17,082 worth of shares (13,898 units at $1.23), increasing direct ownership by 4% to 657,851 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

CTMX· CytomX Therapeutics Inc.

Health Care

Original source

CEO Mccarthy Sean A. converted options into 37,500 shares and sold $17,082 worth of shares (13,898 units at $1.23), increasing direct ownership by 4% to 657,851 units (SEC Form 4) | Quantisnow